RSV is the most common cause of hospitalization in babies, but Sanofi is one of a few companies producing a shot that can help prevent this potentially severe illness. CNN’s Meg Tirrell tours one of their facilities.
BreakdownGenerated by LeadStory AI
- Bayfordis is a new shot that helps prevent severe RSV disease in babies. 13s
- The shot contains antibodies that block RSV from infecting cells. 36s
- Only about two-thirds of babies received the shot last season. 22s
- RSV hospitalizations in the youngest babies were cut by more than half after the shot's introduction. 1m 6s
- Experts believe wider use of the shot could greatly reduce infant RSV hospitalizations. 1m 49s